Sectors
AKTX
Akari Therapeutics, Plc
10.43
2 x 8.01
2 x 12.60
bid
ask
-
0.27
2.52%
2 @ 07:30 PM
9.60 -0.83 (7.96%)
| Ytd | -9.78% | |
| 1y | -65.69% |
9.75
day range
11.40
3.02
52 week range
49.60
| Open | 10.53 | Prev Close | 10.70 | Low | 9.75 | High | 11.40 | Mkt Cap | 20.31M |
| Vol | 80.61K | Avg Vol | 72.19K | EPS | N/A | P/E | N/A | Forward P/E | -0.29 |
| Beta | 0.95 | Short Ratio | 1.92 | Inst. Own | 0.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-22 | 50-d Avg | 9.61 | 200-d Avg | 10.11 | 1yr Est | 80.00 |
| Income Statement | |||
| Operating Expenses | 4.60M | ||
| Research and Development Expense | 2.08M | ||
| Selling, General and Administrative Expense | 2.53M | ||
| Operating Income | -4.60M | ||
| Interest Expense | 80.00K | ||
| Net Income | -4.81M | ||
| Net Income Common Stock | -4.81M | ||
| Net Income Common Stock (USD) | -4.81M | ||
| Consolidated Income | -4.81M | ||
| Earning Before Interest & Taxes (EBIT) | -4.73M | ||
| Earning Before Interest & Taxes (USD) | -4.73M | ||
| Weighted Average Shares | 143.32B | ||
| Weighted Average Shares Diluted | 143.32B | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.75M | ||
| Cash and Equivalents (USD) | 7.75M | ||
| Current Assets | 8.32M | ||
| Total Assets | 38.62M | ||
| Debt Current | 693.00K | ||
| Total Debt | 693.00K | ||
| Current Liabilities | 13.94M | ||
| Total Liabilities | 20.03M | ||
| Accumulated Retained Earnings (Deficit) | -283.81M | ||
| Accumulated Other Comprehensive Income | -695.00K | ||
| Shareholders Equity | 18.60M | ||
| Shareholders Equity (USD) | 18.60M | ||
| Assets Non-Current | 30.30M | ||
| Total Debt (USD) | 693.00K | ||
| Goodwill and Intangible Assets | 30.30M | ||
| Liabilities Non-Current | 6.09M | ||
| Trade and Non-Trade Payables | 9.40M | ||
| Tax Liabilities | 6.09M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 8.04M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.93M | ||
| Issuance (Purchase) of Equity Shares | 8.24M | ||
| Issuance (Repayment) of Debt Securities | -203.00K | ||
| Net Cash Flow from Operations | -3.11M | ||
| Share Based Compensation | 711.00K | ||